{"transactions":[{"id":722091,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.14,"expiration_date":"2027-03-28","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722090,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":2.8,"expiration_date":"2028-01-19","underlying":"Common Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722089,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2027-06-06","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722088,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.91,"expiration_date":"2029-01-02","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722087,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":160334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":6.91,"expiration_date":"2030-01-30","underlying":"Common Shares","underlying_shares":160334},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722086,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":5.15,"expiration_date":"2030-03-10","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722085,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":4.37,"expiration_date":"2031-01-04","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722084,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":1.34,"expiration_date":"2032-01-17","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722083,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0.66,"expiration_date":"2033-01-19","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722082,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest 50% on first anniversary of grant date; remaining options vest 1/3 annually beginning on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":2,"expiration_date":"2034-02-05","underlying":"Common Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":722081,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Common Shares","published_at":"2026-07-01T20:47:27.000Z","date":"2026-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":70,"price":1.72,"value":120.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to a board, shareholder and court-approved business arrangement agreement between the Issuer and Hammi Pharmaceuticals Co. Ltd., a South Korean corporation (\"Hammi\") whereby a subsidiary of Hammi acquired all outstanding shares of the Issuer at a purchase price of C$2.41 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Converted from Canadian price of C$2.41 per share using an exchange rate of C$1.4 = US$1.00."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000912282-26-000894","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228226000894/form4.xml","form_type":"4"}},{"id":1655905,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-02-07T21:39:22.000Z","date":"2024-02-05","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  50% on February 5, 2025; 25% on February 5, 2026; and 25% on February 5, 2027."}],"balance_after":3333,"derivative":{"exercise_price":2,"expiration_date":"2034-02-05","underlying":"Common Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000912282-24-000118","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228224000118/form4.xml","form_type":"4"}},{"id":2049016,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-01-24T00:53:34.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the options vest on January 19, 2024, twenty-five percent (25%) vest on January 19, 2025, and twenty-five percent vest on January 19, 2026."}],"balance_after":100000,"derivative":{"exercise_price":0.66,"expiration_date":"2033-01-19","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-23-001157","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761923001157/doc1.xml","form_type":"4"}},{"id":2431437,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-01-20T22:14:12.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 18, 2022, and vest as follows:  50% vest on January 18, 2023; 25% vest on January 18, 2024; and 25% vest on January 18, 2025."}],"balance_after":50000,"derivative":{"exercise_price":1.34,"expiration_date":"2032-01-17","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-22-001376","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761922001376/doc1.xml","form_type":"4"}},{"id":2463170,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-12-21T16:19:34.000Z","date":"2021-12-20","kind":"purchase","acquired":true,"shares":10000,"price":1.449,"value":14490.0,"ownership":{"direct":true},"balance_after":31671,"source":{"system":"sec-edgar","filing":"0001567619-21-022365","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921022365/doc1.xml","form_type":"4"}},{"id":2499427,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-11-23T20:32:27.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":5417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from Canadian exercise price of C$2.58 using an exchange rate of C$1.2639 = US$1.00."}],"balance_after":0,"derivative":{"exercise_price":2.04,"exercise_date":"2011-11-29","expiration_date":"2021-11-29","underlying":"Common Shares","underlying_shares":5417},"source":{"system":"sec-edgar","filing":"0001567619-21-021040","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921021040/doc1.xml","form_type":"4/A","original_submission_date":"2021-11-19"}},{"id":2499426,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-23T20:32:27.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":5417,"price":2.04,"value":11050.68,"ownership":{"direct":true},"balance_after":21671,"source":{"system":"sec-edgar","filing":"0001567619-21-021040","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921021040/doc1.xml","form_type":"4/A","original_submission_date":"2021-11-19"}},{"id":2503676,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-11-20T01:42:45.000Z","date":"2021-11-19","kind":"disposition_to_issuer","acquired":false,"shares":5714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from Canadian exercise price of C$2.58 using an exchange rate of C$1.2639 = US$1.00."}],"balance_after":0,"derivative":{"exercise_price":2.04,"exercise_date":"2011-11-29","expiration_date":"2021-11-29","underlying":"Common Shares","underlying_shares":5714},"source":{"system":"sec-edgar","filing":"0001567619-21-020908","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921020908/doc1.xml","form_type":"4"}},{"id":2503675,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-20T01:42:45.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":5417,"price":2.04,"value":11050.68,"ownership":{"direct":true},"balance_after":21671,"source":{"system":"sec-edgar","filing":"0001567619-21-020908","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921020908/doc1.xml","form_type":"4"}},{"id":2917337,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-01-06T21:51:44.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 4, 2021, and vest as follows:  50% vest on January 4, 2022; 25% vest on January 4, 2023; and 25% vest on January 4, 2024."}],"balance_after":50000,"derivative":{"exercise_price":4.37,"expiration_date":"2031-01-04","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-000593","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921000593/doc1.xml","form_type":"4"}},{"id":3212074,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Option Grant","published_at":"2020-03-14T00:38:38.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":7.08,"exercise_date":"2021-03-11","expiration_date":"2030-03-10","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-20-006347","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920006347/doc1.xml","form_type":"4/A","original_submission_date":"2020-03-13"}},{"id":3212069,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Option Grant","published_at":"2020-03-13T23:44:28.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from Canadian exercise price of C$7.08 using an exchange rate of 1.3745."}],"balance_after":50000,"derivative":{"exercise_price":5.15,"exercise_date":"2021-03-11","expiration_date":"2030-03-10","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-20-006339","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920006339/doc1.xml","form_type":"4"}},{"id":3295527,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Option Grant","published_at":"2020-02-04T02:39:01.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":160334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the options vest on 1/31/2021.  The remaining 50% vest as follows:  one-half on 1/31/2022 and one-half on 1/31/2023."}],"balance_after":160334,"derivative":{"exercise_price":6.91,"expiration_date":"2030-01-30","underlying":"Common Shares","underlying_shares":160334},"source":{"system":"sec-edgar","filing":"0001567619-20-001976","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920001976/doc1.xml","form_type":"4"}},{"id":3710954,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-04T01:12:38.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest fully on the first anniversary of the grant."}],"balance_after":40000,"derivative":{"exercise_price":1.91,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-19-000425","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761919000425/doc1.xml","form_type":"4"}},{"id":3897812,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-12T21:56:08.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in four equal quarterly installments commencing on September 1, 2018."}],"balance_after":100000,"derivative":{"exercise_price":0.49,"expiration_date":"2028-06-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-18-016230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924318016230/doc4.xml","form_type":"4"}},{"id":4069678,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-02-10T01:01:04.000Z","date":"2018-02-07","kind":"grant","acquired":true,"shares":80331,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 7, 2018, the board of directors of CytoDyn Inc. approved an amendment to its director compensation program, providing for payment in stock options, in lieu of cash, of all unpaid director retainer fees for the four-quarter period ending February 28, 2018. The number of options awarded to each director was determined by applying a price of $0.31 per option, which was the fair value estimate of the option award as of the grant date, using the Black-Scholes option pricing model."}],"balance_after":80331,"derivative":{"exercise_price":0.56,"exercise_date":"2018-02-07","expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":80331},"source":{"system":"sec-edgar","filing":"0000899243-18-003452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924318003452/doc4.xml","form_type":"4"}},{"id":4294821,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-06-05T20:45:17.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to stockholder approval, at the next annual meeting, of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, one third of the options will vest on each date that is six months, 18 months and 30 months following the grant date."}],"balance_after":600000,"derivative":{"exercise_price":0.57,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0000899243-17-015351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924317015351/doc4.xml","form_type":"4"}},{"id":4294820,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":34260,"kind":"person","name":"BURGER DENIS R","position":1,"cik":"0001239414","reported_name":"BURGER DENIS R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-06-05T20:45:17.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to stockholder approval, at the next annual meeting, of the increase in the number of shares of common stock authorized for issuance under the CytoDyn Inc. 2012 Equity Incentive Plan, as amended, the options will vest in four equal quarterly installments commencing on September 1, 2017."}],"balance_after":75000,"derivative":{"exercise_price":0.57,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-17-015351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924317015351/doc4.xml","form_type":"4"}}]}